Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback